Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA

Uložené v:
Podrobná bibliografia
Vydané v:Journal of the American Heart Association Ročník 11; číslo 20; s. e027694
Hlavní autori: Ranasinghe, Priyanga, Addison, Melisande L., Webb, David J.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Hoboken John Wiley and Sons Inc 18.10.2022
Wiley
Predmet:
angiotensinogen
hypertension therapy
reversibility
siRNA
Viewpoints
zilebesiran
ISSN:2047-9980, 2047-9980
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Author Addison, Melisande L.
Ranasinghe, Priyanga
Webb, David J.
AuthorAffiliation 1 Faculty of Medicine, Department of Pharmacology University of Colombo Colombo Sri Lanka
2 University/British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh Edinburgh United Kingdom
AuthorAffiliation_xml – name: 1 Faculty of Medicine, Department of Pharmacology University of Colombo Colombo Sri Lanka
– name: 2 University/British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh Edinburgh United Kingdom
Author_xml – sequence: 1
  givenname: Priyanga
  orcidid: 0000-0002-1522-9276
  surname: Ranasinghe
  fullname: Ranasinghe, Priyanga
  organization: Faculty of Medicine, Department of Pharmacology University of Colombo Colombo Sri Lanka, University/British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh Edinburgh United Kingdom
– sequence: 2
  givenname: Melisande L.
  orcidid: 0000-0002-9577-576X
  surname: Addison
  fullname: Addison, Melisande L.
  organization: University/British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh Edinburgh United Kingdom
– sequence: 3
  givenname: David J.
  orcidid: 0000-0003-0755-1756
  surname: Webb
  fullname: Webb, David J.
  organization: University/British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh Edinburgh United Kingdom
BookMark eNp1ks1u00AQxy1UREvpmeseuSS1vV82ByQTAQmKAJHQ62o_xu5Wzq67a1Pl1kdA4s14hD4JTlKhFsFedmdn_r8Zjf7PkyPnHSTJyyydZhnLzj9W82qa5fk0zTkryZPkJE8Jn5RlkR49eB8nZzFepeNhOce0fJYcY5ZnjBTZSfJrtZFtixauh1BDsK5BXz9VaH0JQXYw9FZHZB2abzsIPbhovXuNKnRh4abz1vXIO3Qho-8CxOgDks48jO9uf6w6uceu-iB7aCxEVI-FMz_sekrd75JvW-8N-rITDQHQ0t8cZlFbVLnG-n1r5xtwd7c_1zI0sJf9c_gXydNathHO7u_T5Nv7d-vZfLL8_GExq5YTTTDrJ0Ypzk1BwWCtTE1KUAWnlOYUF4STkhVEc1orqTQusWF1nSuuKMGpIVQbwKfJ4sA1Xl6JLtiNDFvhpRX7Dx8aIcO4wBYET3VeMAK6YJLoWquMUKmKlFMtCc_wyHpzYHWD2oDR4MZttY-gjzPOXorGfxcl45gxOgJe3QOCvx4g9mJjo4a2lQ78EEXOc1xkOMVkLD0_lOrgYwxQ_2mTpWJnLLEzlhiNJQ7GGhX0L4W2vexHL4yz2Pa_ut-sQ9ri
CitedBy_id crossref_primary_10_3390_ijms25126661
crossref_primary_10_1007_s10557_024_07656_z
crossref_primary_10_1038_s41569_025_01131_4
crossref_primary_10_1016_j_cpcardiol_2024_102627
crossref_primary_10_3389_fcvm_2023_1250073
crossref_primary_10_1038_s41440_024_01989_w
crossref_primary_10_1016_j_ejphar_2024_176467
crossref_primary_10_1016_j_pcad_2024_01_016
crossref_primary_10_1080_17512433_2023_2277330
crossref_primary_10_1016_j_ejim_2023_06_008
crossref_primary_10_1016_j_ncrna_2025_05_001
crossref_primary_10_71079_ASIDE_IM_092125141
crossref_primary_10_1097_CRD_0000000000000645
crossref_primary_10_1161_ATVBAHA_123_319220
crossref_primary_10_1016_j_cellsig_2024_111426
crossref_primary_10_1038_s41440_023_01302_1
crossref_primary_10_1152_ajpheart_00681_2024
Cites_doi 10.1093/nar/gkaa670
10.1016/S0140-6736(21)01330-1
10.1016/j.amepre.2017.08.005
10.1097/MNH.0000000000000586
10.1093/ajh/hpu151
10.1016/S0140-6736(15)01225-8
10.1161/circ.142.suppl_3.14387
10.1111/bcp.14825
10.1159/000507327
10.1161/JAHA.122.026426
10.1038/nbt.4136
10.1038/nbt.2612
10.1016/j.amjcard.2020.08.018
10.1161/HYPERTENSIONAHA.112.198101
10.1016/j.amjhyper.2006.06.003
10.1016/j.jcin.2021.09.020
ContentType Journal Article
Copyright 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
Copyright_xml – notice: 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1161/JAHA.122.027694
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate siRNA Therapeutics in Hypertension
EISSN 2047-9980
ExternalDocumentID oai_doaj_org_article_70c2864ec86a4cfcb145ab8075ca4713
PMC9673665
10_1161_JAHA_122_027694
GroupedDBID 0R~
1OC
53G
5VS
8-1
AAMMB
AAYXX
AAZKR
ACGFO
ACXQS
ADBBV
ADKYN
ADZMN
AEFGJ
AEGXH
AENEX
AGXDD
AIAGR
AIDQK
AIDYY
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GODZA
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
RAH
RNS
RPM
WIN
24P
7X8
5PM
ID FETCH-LOGICAL-c436t-dbb77d85ed3cbdf49eb8755525384749684c75fbabc393d6ff2b7b5430d45cde3
IEDL.DBID DOA
ISICitedReferencesCount 27
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000869713100026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2047-9980
IngestDate Mon Nov 10 04:33:36 EST 2025
Tue Nov 04 02:10:43 EST 2025
Wed Oct 01 13:17:20 EDT 2025
Tue Nov 18 21:13:58 EST 2025
Sat Nov 29 05:05:03 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 20
Language English
License This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c436t-dbb77d85ed3cbdf49eb8755525384749684c75fbabc393d6ff2b7b5430d45cde3
Notes SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Article-3
For Disclosures, see page 5.
The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.
ORCID 0000-0002-1522-9276
0000-0002-9577-576X
0000-0003-0755-1756
OpenAccessLink https://doaj.org/article/70c2864ec86a4cfcb145ab8075ca4713
PMID 36216481
PQID 2723813034
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_70c2864ec86a4cfcb145ab8075ca4713
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9673665
proquest_miscellaneous_2723813034
crossref_primary_10_1161_JAHA_122_027694
crossref_citationtrail_10_1161_JAHA_122_027694
PublicationCentury 2000
PublicationDate 2022-10-18
PublicationDateYYYYMMDD 2022-10-18
PublicationDate_xml – month: 10
  year: 2022
  text: 2022-10-18
  day: 18
PublicationDecade 2020
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
PublicationTitle Journal of the American Heart Association
PublicationYear 2022
Publisher John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley and Sons Inc
– name: Wiley
References Huang S (e_1_3_1_6_2) 2020; 142
e_1_3_1_21_2
e_1_3_1_8_2
e_1_3_1_13_2
e_1_3_1_7_2
e_1_3_1_12_2
e_1_3_1_11_2
e_1_3_1_9_2
e_1_3_1_10_2
e_1_3_1_20_2
e_1_3_1_4_2
e_1_3_1_17_2
e_1_3_1_3_2
e_1_3_1_16_2
e_1_3_1_15_2
e_1_3_1_5_2
e_1_3_1_14_2
e_1_3_1_2_2
e_1_3_1_19_2
e_1_3_1_18_2
References_xml – ident: e_1_3_1_9_2
  doi: 10.1093/nar/gkaa670
– ident: e_1_3_1_2_2
  doi: 10.1016/S0140-6736(21)01330-1
– ident: e_1_3_1_3_2
  doi: 10.1016/j.amepre.2017.08.005
– ident: e_1_3_1_7_2
  doi: 10.1097/MNH.0000000000000586
– ident: e_1_3_1_21_2
  doi: 10.1093/ajh/hpu151
– ident: e_1_3_1_4_2
  doi: 10.1016/S0140-6736(15)01225-8
– volume: 142
  year: 2020
  ident: e_1_3_1_6_2
  article-title: Abstract 14387: Dose‐related reductions in blood pressure with a rna interference (rnai) therapeutic targeting angiotensinogen in hypertensive patients: Interim results from a first‐in‐human phase 1 study of aln‐agt01
  publication-title: Circulation
  doi: 10.1161/circ.142.suppl_3.14387
– ident: e_1_3_1_18_2
  doi: 10.1111/bcp.14825
– ident: e_1_3_1_17_2
– ident: e_1_3_1_20_2
  doi: 10.1159/000507327
– ident: e_1_3_1_14_2
– ident: e_1_3_1_13_2
– ident: e_1_3_1_12_2
  doi: 10.1161/JAHA.122.026426
– ident: e_1_3_1_16_2
  doi: 10.1038/nbt.4136
– ident: e_1_3_1_8_2
  doi: 10.1038/nbt.2612
– ident: e_1_3_1_11_2
  doi: 10.1016/j.amjcard.2020.08.018
– ident: e_1_3_1_10_2
  doi: 10.1161/HYPERTENSIONAHA.112.198101
– ident: e_1_3_1_15_2
– ident: e_1_3_1_5_2
  doi: 10.1016/j.amjhyper.2006.06.003
– ident: e_1_3_1_19_2
  doi: 10.1016/j.jcin.2021.09.020
SSID ssj0000627359
Score 2.4279065
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage e027694
SubjectTerms angiotensinogen
hypertension therapy
reversibility
siRNA
Viewpoints
zilebesiran
Title Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA
URI https://www.proquest.com/docview/2723813034
https://pubmed.ncbi.nlm.nih.gov/PMC9673665
https://doaj.org/article/70c2864ec86a4cfcb145ab8075ca4713
Volume 11
WOSCitedRecordID wos000869713100026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: Directory of Open Access Journals
  customDbUrl:
  eissn: 2047-9980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627359
  issn: 2047-9980
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2047-9980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627359
  issn: 2047-9980
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 2047-9980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627359
  issn: 2047-9980
  databaseCode: WIN
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagQohLxa9YCpWROHBJu5vYsc0tRa1WqF0hulR7i-KfQKTFqZItiAvqIyDxZjxCn4QZJ1s2EogLl0hxnNjKjOfHnvmGkBc21RPNuYxK0C3goIx5pLWWUaKFnowVCsSArn8sZjO5WKi3G6W-MCasgwfufty-GJtYpswZmRbMlEZPGC80QuiaAgRrwPkEq2fDmepkMKhlrnosH7Bq9t9kU9z4i_fAD0sVG6ihgNY_MDGHAZIbGufoLtnuTUWadVO8R244f5_cPukPwx-Qn6efiuWShj29MiAK0nezjM5_Z1S1tPJ0Cp5mE-LUa_-KZvSscl_O68qvaO3pWdF2ZVDqhhbebt5fXX4_xRKF8Nk1hK1rKdi4FPPYMXHZYMg0PcDQd9qlGTaOHmPZNWzXX2nmP1R1GNrXwKhXlz_mIfA8fPNPk39I3h8dzl9Po75EQ2RYkq4iq7UQVnJnE6NtyZTT4ABxHoMcZYKpVDIjeKkLbRKV2LQsY2ACzpKxZdxYlzwiW7727jEmj9vYFU7pgsdMg-VZ8lLZiUi05EqaeET21hTLTY9fjmU0lnnwY9JJjiTOgcR5R-IReXn9wnkH3fH3rgfIAtfdEHM7NAAn5j0n5v_ixBF5vmagHNYoHrwU3tUXbR5jZTc0FmAgMeCswYjDJ776GNC-FUbepfzJ_5jiDrkTY_oGRuTIp2Rr1Vy4Z-SW-byq2maX3BQLuRsWElxPvh3-AibYK0I
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Small+Interfering+RNA+Therapeutics+in+Hypertension%3A+A+Viewpoint+on+Vasopressor+and+Vasopressor%E2%80%90Sparing+Strategies+for+Counteracting+Blood+Pressure+Lowering+by+Angiotensinogen%E2%80%93Targeting+Small+Interfering+RNA&rft.jtitle=Journal+of+the+American+Heart+Association&rft.au=Priyanga+Ranasinghe&rft.au=Melisande+L.+Addison&rft.au=David+J.+Webb&rft.date=2022-10-18&rft.pub=Wiley&rft.eissn=2047-9980&rft.volume=11&rft.issue=20&rft_id=info:doi/10.1161%2FJAHA.122.027694&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_70c2864ec86a4cfcb145ab8075ca4713
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9980&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9980&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9980&client=summon